Stock Quote

Pre-menstrual Syndrome Treatment Market Size, Global Trends, Growth, Opportunities, Market Share and Market Forecast to 2027

The global pre-menstrual syndrome treatment market size is projected to grow at the CAGR of over 3% market during the forecast period 2020 to 2027 and accounted for around USD 1.5 billion in 2019. Pre-menstrual syndrome (PMS) is a medical condition in women that occurs during childbearing age. It is estimated that more than one in three women suffers from PMS; and one in every twenty women demonstrates life disturbing symptoms. PMDD occurs in 3% to 5% of menstruating women.

Pre-menstrual syndrome (PMS) is defined as a condition that affects women at childbearing age and is characterized by symptoms such as bloating, pain, breast tenderness, body pain, fatigue, mood fluctuation, anxiety, etc. where the exact cause of PMS is unknown. According to the American Psychiatric Association, U.S. almost 90% of women of childbearing age experience premenstrual symptoms, and less than 10% are diagnosed with premenstrual dysphoric disorder (PMDD).

According to the recent report published by Research Corridor, the Global Pre-menstrual Syndrome Treatment Market is expected to provide sustainable growth opportunities during the forecast period from 2020 to 2027. This latest industry research study analyzes the Pre-menstrual Syndrome Treatment market by various product segments, applications, regions and countries while assessing regional performances of numerous leading market participants.

The report titled “Pre-menstrual Syndrome Treatment Market – Global Trends, Market Share, Industry Size, Growth, Opportunities, and Forecast – 2020 – 2027” offers a holistic view of the Pre-menstrual Syndrome Treatment industry encompassing numerous stakeholders including raw material suppliers, providers, distributors, consumers and government agencies, among others. Furthermore, the report includes detailed quantitative and qualitative analysis of the global Pre-menstrual Syndrome Treatment market considering market history, product development, regional dynamics, competitive landscape, and key success factors (KSFs) in the industry.

Browse Full report on Global Pre-menstrual Syndrome Treatment Market report at

The report includes a deep-dive analysis of key countries including the U.S., Canada, the U.K., Germany, France, China, Japan, India, Australia, Mexico, Brazil and South Africa, among others. Thereby, the report identifies unique growth opportunities across the world based on trends occurring in various developed and developing economies.

Pre-menstrual Syndrome Treatment Market report summarizes the positive growth rate in upcoming years, and market size with competitive analysis. Our experts have analyzed the historical data to compare with the current market scenario to calculate the market growth in the coming years. The study provides an exhaustive report that includes an executive summary, scope, and forecast of the market.

The global pre-menstrual syndrome treatment market is segmented by drug type as analgesics (pain killers), oral contraceptive pills (OCPs), gonadotropin-releasing hormone (GnRH), antidepressants, ovarian suppressors, diuretics, and benzodiazepines. Common painkillers available for treating PMS are NSAIDS and paracetamol. This segment is majorly dominated by over-the-counter drugs that are cheap and easily available in the market

The Pre-menstrual Syndrome Treatment Market Segmentation:

By  Drug Type, 2018–2027 ($ Millon)

  • Analgesics (pain killers)
  • Oral Contraceptive Pills (OCPs)
  • Gonadotropin-releasing Hormone (GnRH)
  • Antidepressants
  • Ovarian Suppressors
  • Diuretics
  • Benzodiazepines

By Region, 2018–2027 ($ Millon)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

To know more about the study, make an inquiry before purchase @

List of Key companies:

  • Alva-Amco Pharmacal Cos., Inc.
  • Bayer, Inc.
  • Chattem, Inc. (Sanofi)
  • DEKK-TEC, Inc.
  • Lane Health Products Ltd
  • McNeil Consumer Healthcare
  • MetP Pharma AG
  • Pherin Pharmaceuticals, Inc.
  • Umecrine Mood AB

Key Questions Answered by Pre-menstrual Syndrome Treatment Market Report

  • Product popularity and adoption based on various country-level dynamics
  • Regional presence and product development for leading market participants
  • Market forecasts and trend analysis based on ongoing investments and economic growth in key countries
  • Competitive landscape based on revenue, product offerings, years of presence, number of employees and market concentration, among others
  • number of employees and market concentration, among others

To know more about this study, request a free sample report @

Other Related Reports:

Contact Information:

Media Contact:
Company Name: Research Corridor
Contact Person: Mr. Vijendra Singh
Contact no: +91 989-368-5690
Visit us:

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.